Literature DB >> 7069578

Comparative physiologically based pharmacokinetics of hexobarbital, phenobarbital and thiopental in the rat.

Y Igari, Y Sugiyama, S Awazu, M Hanano.   

Abstract

A physiologically based pharmacokinetic model, which is an extension of the Bischoff-Dedrick multiorgan model, was developed to described the kinetics of barbiturates (hexobarbital, phenobarbital, and thiopental) in the rat. The model is composed of 11 organ or tissue compartments. The brain compartment was featured as a nonflow-limited organ for some low lipid soluble barbiturates. Michaelis-Menten constants for drug metabolism (Km, Vmax) were determined from in vitro experiments using liver microsomes. Binding of drugs to plasma and tissue proteins was measured in vitro using an equilibrium dialysis method. Distribution of drugs to red blood cells was measured in vitro with thiopental exhibiting a concentration dependent distribution. Penetration rates of the barbiturates into the brain were predicted on the basis of their lipid solubilities. A set of mass balance equations included terms for the inflow and outflow of drug carried by the perfusing blood, drug metabolism, protein binding, and penetration rate into the brain as well as blood flow rate and tissue mass. Solution of the system of equations yielded the time courses of drugs in each organ. However, predicted time course of drugs in plasma and brain were not in good agreement with those observed. Therefore, the tissue to plasma distribution ratios evaluated from in vivo experiments were substituted for the in vitro values, resulting in fairly good agreement between predicted and observed values.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7069578     DOI: 10.1007/bf01059183

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  27 in total

1.  The importance of dissociaton constant and lipid-solubility in influencing the passage of drugs into the cerebrospinal fluid.

Authors:  B B BRODIE; H KURZ; L S SCHANKER
Journal:  J Pharmacol Exp Ther       Date:  1960-09       Impact factor: 4.030

2.  The fate of thiopental in man and a method for its estimation in biological material.

Authors:  B B BRODIE; L C MARK
Journal:  J Pharmacol Exp Ther       Date:  1950-01       Impact factor: 4.030

3.  Quantitative determination of cytochrome P-450 in rat liver homogenate.

Authors:  T Matsubara; M Koike; A Touchi; Y Tochino; K Sugeno
Journal:  Anal Biochem       Date:  1976-10       Impact factor: 3.365

Review 4.  Physiologically based pharmacokinetic models for anticancer drugs.

Authors:  H S Chen; J F Gross
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

5.  Cytochrome P-450 measurement in rat liver homogenate and microsomes. Its use for correction of microsomal losses incurred by differential centrifugation.

Authors:  J G Joly; C Doyon; Y Peasant
Journal:  Drug Metab Dispos       Date:  1975 Nov-Dec       Impact factor: 3.922

6.  Critical evaluation of use of effective protein fractions in developing pharmacokinetic models for drug distribution.

Authors:  D Shen; M Gibaldi
Journal:  J Pharm Sci       Date:  1974-11       Impact factor: 3.534

7.  Hepatic organelle interaction. I. Spectral investigation during drug biotransformation.

Authors:  D L Cinti; J B Schenkman
Journal:  Mol Pharmacol       Date:  1972-05       Impact factor: 4.436

8.  [Increased synthesis and inhibited breakdown during the increase in microsomal cytochromes P-450 and b-5 by phenobarbital].

Authors:  H Greim
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

9.  Lidocaine disposition kinetics in monkey and man. I. Prediction by a perfusion model.

Authors:  N Benowitz; F P Forsyth; K L Melmon; M Rowland
Journal:  Clin Pharmacol Ther       Date:  1974-07       Impact factor: 6.875

10.  Increased penetration of barbital through the bloodbrain barrier in the rat after pretreatment with probenecid.

Authors:  G Wahlström
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1978-10
View more
  21 in total

1.  Prediction of in vivo tissue distribution from in vitro data. 3. Correlation between in vitro and in vivo tissue distribution of a homologous series of nine 5-n-alkyl-5-ethyl barbituric acids.

Authors:  Peter Ballard; David E Leahy; Malcolm Rowland
Journal:  Pharm Res       Date:  2003-06       Impact factor: 4.200

Review 2.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 3.  Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

Authors:  G M Pacifici; A Viani
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

4.  Discrepancies in pharmacokinetic parameter estimation between bolus and infusion studies in the perfused rat hindlimb.

Authors:  A C Heatherington; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1995-10

5.  Trapezoidal area method for simulating physiological pharmacokinetics of drugs in animals.

Authors:  X D Liu; J Chen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Oct-Dec       Impact factor: 2.441

6.  From piecewise to full physiologic pharmacokinetic modeling: applied to thiopental disposition in the rat.

Authors:  W F Ebling; D R Wada; D R Stanski
Journal:  J Pharmacokinet Biopharm       Date:  1994-08

7.  An understanding of flow- and diffusion-limited vs. carrier-mediated hepatic transport: a simulation study.

Authors:  W P Geng; K Poon; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1995-08

8.  Pharmacokinetic modeling of non-linear brain distribution of fluvoxamine in the rat.

Authors:  Marian Geldof; Jan Freijer; Ludy van Beijsterveldt; Meindert Danhof
Journal:  Pharm Res       Date:  2007-08-21       Impact factor: 4.200

9.  In vivo relationships between the cerebral pharmacokinetics and pharmacodynamics of thiopentone in sheep after short-term administration.

Authors:  R N Upton; G L Ludbrook; C Grant; E C Gray
Journal:  J Pharmacokinet Biopharm       Date:  1996-02

10.  Plasma concentration clamping in the rat using a computer-controlled infusion pump.

Authors:  L L Gustafsson; W F Ebling; E Osaki; S Harapat; D R Stanski; S L Shafer
Journal:  Pharm Res       Date:  1992-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.